EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Impact of incretin therapies on biochemical and imaging outcomes in metabolic dysfunction–associated steatotic liver disease

Nicole Ann Tesoro, Frederick Berro Rivera, Nathan Ross B Bantayan, John Vincent Magalong, Romaine Tomada, Maria Antonia Wong, Gabriel Tangco, Polyn Luz Pine, Jasvin Kurundrayil Manha, Elora Shyama Tanni, Christine Lin, Sung-Ki Lee und 2 weitere

American Journal of Preventive Cardiology · 2026-08 · 28 · 101623

DOI: 10.1016/j.ajpc.2026.101623 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Preventive Cardiology, 2026-08. Verfasst von Nicole Ann Tesoro und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, NYC Health + Hospitals/South Brooklyn Health, NY, USA. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

GLP-1 receptor agonistsHepatic steatosisIncretin therapiesLiver fibrosisMASLDNAFLDTirzepatide

Autor:innen und Institutionen

  • Department of Medicine, NYC Health + Hospitals/South Brooklyn Health, NY, USA.
  • Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA.
  • University of the Philippines College of Medicine, Manila, Philippines.
  • College of Medicine, San Beda University, Mendiola, Manila, Philippines.
  • College of Medicine, University of the East Ramon Magsaysay Memorial Medical Center, Manila, Philippines.
  • Medicine Clinical Trial Office, Icahn School of Medicine at Mount Sinai, NY, USA.

Zitieren

APA

Tesoro, N. A., Rivera, F. B., Bantayan, N. R. B., Magalong, J. V., Tomada, R., Wong, M. A., Tangco, G., Pine, P. L., Manha, J. K., Tanni, E. S., Lin, C., Lee, S. K., Lara-Breitinger, K., & Gulati, M. (2026). Impact of incretin therapies on biochemical and imaging outcomes in metabolic dysfunction–associated steatotic liver disease. American Journal of Preventive Cardiology, 28, 101623. https://doi.org/10.1016/j.ajpc.2026.101623

Vancouver

Tesoro NA, Rivera FB, Bantayan NRB, Magalong JV, Tomada R, Wong MA, et al. Impact of incretin therapies on biochemical and imaging outcomes in metabolic dysfunction–associated steatotic liver disease. American Journal of Preventive Cardiology. 2026;28:101623. doi:10.1016/j.ajpc.2026.101623

BibTeX
@article{Tesoro2026,
  author = {Tesoro, Nicole Ann and Rivera, Frederick Berro and Bantayan, Nathan Ross B and Magalong, John Vincent and Tomada, Romaine and Wong, Maria Antonia and Tangco, Gabriel and Pine, Polyn Luz and Manha, Jasvin Kurundrayil and Tanni, Elora Shyama and Lin, Christine and Lee, Sung-Ki and Lara-Breitinger, Kyla and Gulati, Martha},
  title = {Impact of incretin therapies on biochemical and imaging outcomes in metabolic dysfunction–associated steatotic liver disease},
  journal = {American Journal of Preventive Cardiology},
  year = {2026},
  volume = {28},
  pages = {101623},
  doi = {10.1016/j.ajpc.2026.101623}
}
Kostenlos starten →